Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on June 4, 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025
GlobeNewswire
·
June 4, 2025
Information relative au …
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
GlobeNewswire
·
June 4, 2025
SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech …
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 2:00 p.m. ET. The webcast …
NeuroPace Secures Up to $75 Million in Debt Financing
GlobeNewswire
·
June 4, 2025
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million credit …
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its …
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
GlobeNewswire
·
June 4, 2025
GERMANTOWN, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
BRISBANE, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, …
RAPT Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 4, 2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
NurExone Strengthens Path to Clinical Trials for ExoPTEN with New Manufacturing Process Validation
GlobeNewswire
·
June 4, 2025
TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that on May 22, 2025, it presented new manufacturing process data at the 4th …
Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune Diseases
GlobeNewswire
·
June 4, 2025
Advances Cullinan’s leadership in T cell engager (TCE) development for autoimmune diseases with both a CD19 TCE and BCMA TCE in its pipeline Strengthens Cullinan portfolio of autoimmune programs with the opportunity to address a broader range of diseases …
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics
GlobeNewswire
·
June 4, 2025
See-Mode’s commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid and breast will be integrated into RadNet’s DeepHealth population health solutions Real-world deployment of See-Mode’s FDA-approved …
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
GlobeNewswire
·
June 4, 2025
GAITHERSBURG, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
SFDA Joins MedDRA Management Committee: The 6th Global Regulatory Body
EIN Presswire
·
June 4, 2025
RIYADH, SAUDI ARABIA, June 4, 2025 /EINPresswire.com/ -- In a move that highlights Saudi Arabia’s growing prominence in global pharmaceutical governance, the Saudi Food and Drug Authority (SFDA) has been officially elected to the Management Committee of …
28% of Brits avoid the gym because it’s ‘boring’
EIN Presswire
·
June 4, 2025
UNITED KINGDOM, June 4, 2025 /EINPresswire.com/ -- A new piece of research could hold the key to getting around nine million people in the UK to be more active, offering some positive news for the NHS which spends around £6.5 million annually on treating …
ABL Diagnostics to Present Breakthrough Scientific Data at the European Meeting on HIV & Hepatitis 2025
EIN Presswire
·
June 4, 2025
Featuring New Advances in Automated Bioinformatics and HIV Drug Resistance Detection Using Next-Generation Sequencing WOIPPY, FRANCE, June 4, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in …
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight
GlobeNewswire
·
June 4, 2025
New York, USA, June 04, 2025 (GLOBE NEWSWIRE) -- Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight The AI in remote patient monitoring market is witnessing strong growth, driven by the increasing prevalence of …
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
GlobeNewswire
·
June 4, 2025
RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) -- As part of Saudi Arabia’s broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital …
As Interest Grows for New Agents to Treat Thalassemia, Hematologists Begin Early Identification of Ideal Patients for Gene Therapies Vs. New Therapeutic Options
GlobeNewswire
·
June 4, 2025
EXTON, PA, June 04, 2025 (GLOBE NEWSWIRE) -- Despite the promise of new curative strategies for beta thalassemia, such as Casgevy (Vertex) and Zynteglo (bluebird bio), most transfusion-dependent thalassemia patients remain tethered to long-term transfusion …
KLĒNR Soaps & Sundries Donates Two Years’ Worth of Premium Soaps to America’s VetDogs
GlobeNewswire
·
June 4, 2025
Smithtown, New York, June 04, 2025 (GLOBE NEWSWIRE) -- SMITHTOWN, NEW YORK, June 04, 2025 – America’s VetDogs, a national nonprofit that provides service dogs to veterans and first responders free of charge, is excited to announce a partnership with KLĒNR …